Danhong Injection for the Treatment of Hypertensive Nephropathy: A Systematic Review and Meta-Analysis
- PMID: 32636745
- PMCID: PMC7316888
- DOI: 10.3389/fphar.2020.00909
Danhong Injection for the Treatment of Hypertensive Nephropathy: A Systematic Review and Meta-Analysis
Abstract
Objective: Danhong Injection (DHI) has been widely used to treat various diseases in China for many years. The objective of this systematic review was to evaluate the efficacy of DHI combined with antihypertensive drugs for treatment of hypertensive nephropathy.
Methods: Seven databases were searched from inception to September 21st, 2019. Randomized controlled trials comparing DHI combined with antihypertensive drugs versus antihypertensive drugs alone were extracted. The primary outcome was microalbuminuria (mALB). Secondary outcomes included systolic blood pressure (SBP), diastolic blood pressure (DBP), and serum creatinine (SCr).
Results: Fifteen studies were included in the meta-analysis, which indicated that DHI combined with antihypertensive drugs has advantages compared with antihypertensive drugs alone for reducing mALB [weighted mean difference (WMD) = -12.86, 95% confidence interval (CI) (-14.72, -11.0), P < 0.01], lowering SBP [WMD = -2.84, 95% CI (-4.56, -1.12), P = 0.001] and DBP [WMD = -2.38, 95% CI (-4.34, -0.43), P = 0.017], and decreasing SCr [WMD = -40.45, 95% CI (-55.69, -25.21), P < 0.01].
Conclusion: The combination of DHI with antihypertensive drugs appears to be more effective than antihypertensive drugs alone for treatment of hypertensive nephropathy. A moderate duration (≤4 weeks) of DHI administration is reasonable, and longer treatment with DHI should be avoided, according to the results of subgroup analysis.
Keywords: Danhong injection; hypertensive nephropathy; meta-analysis; systematic review; traditional Chinese medicine.
Copyright © 2020 Li, Yan, Qian, Wu, Zheng and Fang.
Figures










Similar articles
-
Efficacy of Huangqi Injection in the Treatment of Hypertensive Nephropathy: A Systematic Review and Meta-Analysis.Front Med (Lausanne). 2022 Apr 25;9:838256. doi: 10.3389/fmed.2022.838256. eCollection 2022. Front Med (Lausanne). 2022. PMID: 35547210 Free PMC article.
-
Combined Therapy of Hypertensive Nephropathy with Breviscapine Injection and Antihypertensive Drugs: A Systematic Review and a Meta-Analysis.Evid Based Complement Alternat Med. 2018 Dec 20;2018:2958717. doi: 10.1155/2018/2958717. eCollection 2018. Evid Based Complement Alternat Med. 2018. PMID: 30671127 Free PMC article. Review.
-
Combined therapy of hypertensive nephropathy with ginkgo leaf extract and dipyridamole injection and antihypertensive drugs: A systematic review and meta-analysis.Medicine (Baltimore). 2021 May 14;100(19):e25852. doi: 10.1097/MD.0000000000025852. Medicine (Baltimore). 2021. PMID: 34106629 Free PMC article.
-
Effects of Three Traditional Chinese Fitness Exercises Combined with Antihypertensive Drugs on Patients with Essential Hypertension: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials.Evid Based Complement Alternat Med. 2021 Oct 31;2021:2570472. doi: 10.1155/2021/2570472. eCollection 2021. Evid Based Complement Alternat Med. 2021. PMID: 34754311 Free PMC article.
-
Efficacy and Safety of Sodium Tanshinone IIA Sulfonate Injection on Hypertensive Nephropathy: A Systematic Review and Meta-Analysis.Front Pharmacol. 2019 Dec 24;10:1542. doi: 10.3389/fphar.2019.01542. eCollection 2019. Front Pharmacol. 2019. PMID: 31920681 Free PMC article.
Cited by
-
Predicting Coupled Herbs for the Treatment of Hypertension Complicated with Coronary Heart Disease in Real-World Data Based on a Complex Network and Machine Learning.Evid Based Complement Alternat Med. 2022 Jan 22;2022:8285111. doi: 10.1155/2022/8285111. eCollection 2022. Evid Based Complement Alternat Med. 2022. PMID: 35103067 Free PMC article.
-
Effects of tanshinone combined with valsartan on hypertensive nephropathy and its influence on renal function and vascular endothelial function.Am J Transl Res. 2021 May 15;13(5):4788-4795. eCollection 2021. Am J Transl Res. 2021. PMID: 34150059 Free PMC article.
-
Chinese herbal injection for cardio-cerebrovascular disease: Overview and challenges.Front Pharmacol. 2023 Feb 24;14:1038906. doi: 10.3389/fphar.2023.1038906. eCollection 2023. Front Pharmacol. 2023. PMID: 36909150 Free PMC article. Review.
-
The biomedical knowledge graph of symptom phenotype in coronary artery plaque: machine learning-based analysis of real-world clinical data.BioData Min. 2024 May 21;17(1):13. doi: 10.1186/s13040-024-00365-1. BioData Min. 2024. PMID: 38773619 Free PMC article.
-
Summarizing the Effective Herbs for the Treatment of Hypertensive Nephropathy by Complex Network and Machine Learning.Evid Based Complement Alternat Med. 2021 Jun 11;2021:5590743. doi: 10.1155/2021/5590743. eCollection 2021. Evid Based Complement Alternat Med. 2021. PMID: 34194519 Free PMC article.
References
-
- Baobao L. (2017). Observation on the effect of trimetazidine combined with Danhong Injection on hypertensive nephropathy. Modern J. Integrated Traditional Chin. Western Med. 26, 1113–1114. 10.3969/j.issn.1008-8849.2017.10.032 - DOI
-
- Changan H., Meiyu Z. (2008). Danhong Injection was used to treat 52 aged patients with hypertensive renal damage. Zhejiang J. Traditional Chin. Med. 43, 59. 10.3969/j.issn.0411-8421.2008.01.043 - DOI
-
- Changjiang L. (2015). Observation on the curative effect of combined traditional Chinese and western medicine on hypertensive renal damage in elderly patients. Northern Pharm. 12, 195. 10.3969/j.issn.1674-6805.2012.05.036 - DOI
Publication types
LinkOut - more resources
Full Text Sources